Genmab | Profitto Lordo Sulle Vendite

Gross Profit On Sales Cambiamento Data
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Almirall EUR 359.69M 23.71M 2023-06
Amarin USD 42.5M 14.47M 2023-09
Amgen USD 5.08B 14M 2023-12
AstraZeneca USD 9.43B 15M 2023-09
Bayer EUR 5.53B 796M 2023-09
Demant DKK 8.17B 587M 2023-06
Galapagos EUR 130.64M 30.51M 2023-09
GN Store Nord DKK 2.23B 2M 2023-09
GRIFOLS EUR 689.83M 58M 2023-12
Hikma Pharmaceutical USD 733M 91M 2023-06
Insmed USD 65.25M 2.88M 2023-12
Lonza CHF 1.11B 134M 2023-06
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
UCB EUR 1.79B 24M 2023-06



Genmab Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.